Quorum Review IRB Launches Streamlined Retrospective Chart Review
Seattle, WA (PRWEB) September 09, 2014 -- Quorum Review IRB, the industry leader in central IRB services, announces a new streamlined service for Retrospective Chart Reviews. The service was piloted earlier this year with several clients and was rolled out to all Quorum’s clients with the new Expeditable Research Review offering. The Retrospective Chart Review process is designed to simplify the IRB application process for researchers interested in studying data from available medical charts or HER systems. The new process is expected to provide exceptional benefit to investigators conducting such studies in universities, academic medical centers and hospital settings.
Quorum achieved its process simplification by streamlining its form requirements and combining the necessary elements into one customized document. This new form includes the option to request a consent and HIPAA waiver. If the study qualifies as Expeditable Research, the turnaround time for IRB review can be as quick as one day.
Quorum’s CEO Cami Gearhart says of the new service, “Quorum has made great progress to simplify our processes for clinical researchers, and our new Retrospective Chart Review is a terrific example of our success in making IRB review for this type of research more efficient for our clients.”
Retrospective Chart Reviews (RCRs) are a specific type of research design that involves mining pre-recorded patient data and using the results to answer a pre-determined research question. They are often conducted by first time clinical investigators within institutional and academic settings. Unlike other types of clinical research, these studies do not generally require consent and therefore can be reviewed more quickly as consent documents don’t need to be evaluated.
For more details on Quorum Review’s new Retrospective Chart Review, visit http://www.quorumreview.com/retrochart.
About Quorum Review IRB
Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of human clinical research since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services include 15 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure Web Portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, international ethics review, a specialized Phase I team, and unique processes for minimal risk research.
Arri Burgess, Quorum Review IRB, http://www.quorumreview.com/, +1 (206) 902-3381, [email protected]
Share this article